Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial

• Main Authors: Joan T. Price (Author), Bellington Vwalika (Author), Bethany L. Freeman (Author), Stephen R. Cole (Author), Helen B. Mulenga (Author), Jennifer Winston (Author), Felistas M. Mbewe (Author), Elwyn Chomba (Author), Lynne M. Mofenson (Author), Dwight J. Rouse (Author), Robert L. Goldenberg (Author), Jeffrey S. A. Stringer (Author)
• Format: Book
• Published: BMC, 2019-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Each year, an estimated 15 million babies are born preterm, a global burden borne disproportionately by families in lower-income countries. Maternal HIV infection increases a woman's risk of delivering prematurely, and antiretroviral therapy (ART) may compound this risk. Whi...